Renexxion Ireland Limited ("Renexxion"), a private biopharmaceutical company focused on advancing new therapies for patients ...

DA-9701 therapy was found to improve the severity of gastrointestinal symptom–related quality of life and severity in patients with Parkinson disease, with no adverse effects on motor symptoms, ...

Microbiome is as unique as a fingerprint. These bacteria perform important jobs, including maintaining the intestinal barrier ...

Scientists have studied one ofd the most common laxatives in the world to reveal more about how the regulation of fluid flow ...

Cystic fibrosis gastrointestinal disease includes nutrient malabsorption and intestinal inflammation. We show that the abundances of Escherichia coli in fecal microbiota were significantly higher in ...

Medically reviewed by Qin Rao, MD Irritable bowel syndrome (IBS) is a group of symptoms that can cause abdominal pain and ...

The designation is based on positive topline data from a phase 2 study of 120 adults following open-heart surgery. The Food and Drug Administration (FDA) has granted Fast Track designation to LB1148 ...

For every ten adults in the world, four suffer from functional gastrointestinal disorders of varying severity. This is shown by a study of more than 73,000 people in 33 countries. University of ...

Elimination diets are frequently used to manage gastrointestinal symptoms, such as abdominal pain, bloating, nausea, constipation, and diarrhea, which do not have an organic explanation. The most ...

After COVID-19, the risk for GI diagnoses and AN was increased, compared with the other control populations, except for patients with GI diagnoses after CMV. COVID-19 is associated with an increased ...